Progressive trismus and burning mouth in an areca nut chewer
32-year-old male
§Chief complaint
Burning sensation with spicy food and progressively reduced mouth opening
§Medical & dental history
- 01Chews areca nut (gutkha) 10-12 sachets daily for 12 years
- 02No tobacco smoking
- 03Difficulty with dental treatment because of limited opening
§Clinical examination
- 01Blanched, marble-like buccal mucosa with palpable vertical fibrous bands bilaterally
- 02Maximum interincisal opening 22 mm
- 03Depapillated tongue with reduced protrusion; shrunken uvula
- 04No ulceration or discrete white patch; no lymphadenopathy
§ figuresFigures (1)
Fig. 1Generalized submucous fibrosis of oral cavity
“Oral submucous fibrosis” · Saivishnu.ponnapalli · CC BY-SA 4.0 · Wikimedia Commons
Verified open-access images only, reproduced for education under their stated licences · no AI-generated or illustrative artwork · Oral Submucous Fibrosis figures pending faculty review.
§Differential diagnosis
§Final diagnosis
Oral submucous fibrosis, clinical stage III (trismus with functional limitation)
Palpable fibrous bands with mucosal blanching and progressive trismus in a chronic areca nut user is clinically diagnostic; biopsy confirms juxta-epithelial hyalinisation and assesses for coexisting dysplasia, the key malignancy concern.
§Investigations
- 01Incisional biopsy of buccal mucosa — grading of fibrosis and exclusion of dysplasia
- 02Haemoglobin and haematinics — anaemia is common and worsens mucosal atrophy
- 03Serial measurement of mouth opening and photographs
§Radiology
- 01No specific radiographic findings; OPG to assess dental status before treatment
§Treatment plan
- 01Absolute cessation of areca nut and any tobacco product with counselling
- 02Nutritional support: iron, B-complex, antioxidants
- 03Intralesional corticosteroid and hyaluronidase injections
- 04Active physiotherapy with mouth-opening exercises and devices
- 05Surgical band release with coronoidectomy and grafting for severe refractory trismus
- 06Lifelong surveillance for malignant transformation
§Surgical procedure
- 01Intralesional triamcinolone with hyaluronidase weekly for 6 weeks combined with physiotherapy
§Histopathology report
Atrophic epithelium with juxta-epithelial hyalinisation, dense collagen bundles replacing the lamina propria, reduced vascularity and a sparse chronic inflammatory infiltrate. No epithelial dysplasia identified.
§Follow-up & outcome
- 016 weeks — opening improved from 22 mm to 29 mm; burning resolved
- 026 months — opening 33 mm, habit stopped
- 03Annual review for malignant transformation, lifelong
Outcome: Functional improvement and symptom relief with habit cessation and conservative therapy; surgery avoided.
§Discussion
- 01Areca nut arecoline drives fibroblast proliferation and collagen cross-linking while reducing collagen degradation.
- 02Malignant transformation is reported in 7-13% of cases, so OSMF is a potentially malignant disorder requiring lifelong follow-up.
- 03Fibrosis does not reverse — treatment aims to arrest progression and improve function.
§Clinical pearls / learning points
- 01Palpate for bands — blanching alone can be missed in dark mucosa.
- 02Cessation is the only intervention that alters the disease trajectory.
- 03Trismus makes future oral cancer detection harder, which compounds the risk.
§Viva questions
What is the aetiological agent?
Areca nut, specifically arecoline and related alkaloids; chillies, nutritional deficiency and genetic susceptibility are cofactors.
What is the malignant transformation rate?
Approximately 7-13% over long-term follow-up.
§MCQs
Q1The primary aetiological factor in oral submucous fibrosis is:
Q2The histological hallmark is:
§ evidenceReferences & Evidence
Current Classification
WHO Classification of Tumours Online — Head and Neck
IARC / WHO · 2022
Continuously updated online edition of the WHO head and neck tumour classification.
Evidence summary
Highest level of evidence linked to this page: WHO / Official Classification.
- L1 · Classification — 1
- L2 · Guideline — 1
- L6 · Textbook — 3
1 linked source was published from 2024 onwards. Where guidance is limited or contested, rely on the higher-level sources above rather than this summary. Educational use only — not a substitute for clinical judgement.
Content last reviewed
September 2026
Evidence last reviewed
September 2026
Next scheduled review
September 2027
Review status
EVIDENCE REVIEWED
Search latest PubMed evidence
Last literature search: 7 September 2026
Current Classification
IARC / WHO. IARC · 2022
Continuously updated online edition of the WHO head and neck tumour classification.
Clinical Guidelines
Warnakulasuriya S, Kujan O, Aguirre-Urizar JM et al.. Oral diseases · 2021 · 27(8):1862-1880
WHO collaborating centre consensus on nomenclature and classification of oral potentially malignant disorders.
Histopathology References
Barnes L. CRC Press · 2008
Detailed histopathological reference for head and neck diagnostic criteria.
Textbook References
Neville BW, Damm DD, Allen CM et al.. Elsevier · 2024
Standard reference textbook of oral and maxillofacial pathology used throughout this atlas.
Rajendran R, Sivapathasundharam B. Elsevier · 2020
Undergraduate and postgraduate oral pathology textbook widely used in BDS and FCPS curricula.
Additional sources cited on this page
- Warnakulasuriya S, Kerr AR. Oral submucous fibrosis: a review. J Oral Pathol Med 2021.
§Similar cases
81 cases in the library